Abstract
Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC) tumorigenesis. However, the mechanism(s) connecting EBV infection and NPC remain unclear. Recently, a new class of EBV microRNAs (miRNAs) has been described. To determine how EBV miRNAs control the expression of host genes, and to understand their potential role in NPC tumorigenesis, we profiled the expression of 44 mature EBV miRNAs and potential host genes in NPC and non-tumor nasopharyngeal epithelial tissues. We found that 40 EBV miRNAs from the BART transcript were highly expressed in NPC. Analysis of potential BART miRNA target genes revealed that 3140 genes and several important pathways might be involved in the carcinogenesis of NPC. A total of 105 genes with potential EBV miRNA binding sites were significantly downregulated, suggesting that EBV miRNAs may regulate these genes and contribute to NPC carcinogenesis. An EBV miRNA and host gene regulation network was generated to provide useful clues for validating of EBV miRNA functions in NPC tumorigenesis.
Article PDF
Similar content being viewed by others
References
Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, Li XL, Hu DX, Tan C, Xiang JJ, Zhou J, Deng H, Fan SQ, Li WF, Wang R, Zhou M, Zhu SG, Lu HB, Qian J, Zhang BC, Wang JR, Ma J, Xiao BY, Huang H, Zhang QH, Zhou YH, Luo XM, Zhou HD, Yang YX, Dai HP, Feng GY, Pan Q, Wu LQ, He L, Li GY. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res, 2004, 64: 1972–1974
Barth S, Meister G, Grasser FA. EBV-encoded miRNAs. Biochim Biophys Acta, 2011, 1809: 631–640
Li L, He XS, Luo Q, Zhang ZW, Yao XJ, Chen SQ, Li CC, Wang LL, Duan R, Chen ZC. Effect of STGC3 gene deletion mutant on the growth of CNE2 cells. Prog Biochem Biophys, 2011, 38: 248–253
Xiang B, Wang W, Li WJ, Tang K, Zeng ZY, Li XL, Li GY. NOR1 regulates morphogenetic cell behavior in vitro coincident with inhibition of a non-canonical Wnt-signaling cascade. Prog Biochem Biophys, 2012, 39: 887–892
Liao QJ, Guo XF, Li XL, Li XY, Chen P, Liang F, Tang HL, Deng M, Wu MH, Ma J, Xiong W, Li GY. Analysis of the contribution of nasopharyngeal epithelial cancer cells to the induction of a local inflammatory response. J Cancer Res Clin Oncol, 2013, 138: 57–64
Li S, Du H, Wang Z, Zhou L, Zhao X, Zeng Y. Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma. Sci China Life Sci, 2010, 53: 524–530
Zhang ZW, Zhang Q, Yu YH, Ouyang YM, He ZM. Influence of Epstein-Barr virus encoded latent membrane protein 1-CTAR(3) for proteinic expression and cellular proliferation of NP69 cells. Prog Biochem Biophys, 2009, 36: 580–586
Wang Z, Yang S, Zhou L, Du H, Mo W, Zeng Y. Specific cellular immune responses in mice immunized with DNA, adeno-associated virus and adenoviral vaccines of Epstein-Barr virus-LMP2 alone or in combination. Sci China Life Sci, 2011, 54: 263–266
Gong ZJ, Zhang SS, Zhang WL, Huang H, Li Q, Deng H, Ma J, Zhou M, Xiang JJ, Wu MH, Li XY, Xiong W, Li Y, Zeng ZY, Li GY. Long non-coding RNAs in cancer. Sci China Life Sci, 2012, 55: 1120–1124
Feederle R, Haar J, Bernhardt K, Linnstaedt SD, Bannert H, Lips H, Cullen BR, Delecluse HJ. The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes. J Virol, 2011, 85: 9801–9810
Luo J, Teng M, Fan J, Wang F, Zhou L, Deng R, Zhang G. Marek’s disease virus-encoded microRNAs: genomics, expression and function. Sci China Life Sci, 2010, 53: 1174–1180
Yu J, Wang F. Recent progress in microRNA study: Benefits from technique advance. Sci China Life Sci, 2012, 55: 649–650
Zhang Y. Progress, challenges and new concepts in microRNAs. Sci China Life Sci, 2011, 54: 1096
Zhang Y, Li YK. Regulation of innate receptor pathways by microRNAs. Sci China Life Sci, 2013, 56: 13–18
Wang G, Dong X, Hu J, Tian W, Yuchi J, Wang Y, Wu X. Long-term ex vivo monitoring of in vivo microRNA activity in liver using a secreted luciferase sensor. Sci China Life Sci, 2011, 54: 418–425
Jin YF, Xu GM, Li Y, Meng L, Jiang YH, Guo JF, Ding XF. A novel normalization approach for microRNA quantitative PCR. Prog Biochem Biophys, 2011, 38: 473–481
Deng M, Tang HL, Zhou YH, Zhou M, Xiong W, Zheng Y, Ye QR, Zeng X, Liao QJ, Guo XF, Li XY, Ma J, Li GY. miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J Cell Sci, 2011, 124: 2997–3005
Luo HT, Zhao Y. The functional roles of microRNA. Prog Biochem Biophys, 2012, 39: 979–980
Jiang X, Zhang JT, Chan HC. Ion channels/transporters as epigenetic regulators?—a microRNA perspective. Sci China Life Sci, 2012, 55: 753–760
Liang JW, Wang P, Chen L, Hu YQ, Sun Y. miR-133b may regulate mouse B cell development by targeting the transcription factor foxO1. Prog Biochem Biophys, 2011, 38: 744–750
Chen WJ, Yin K, Zhao GJ, Tang CK. microRNAs: a new mechanism for regulation of lipid metabolism. Prog Biochem Biophys, 2011, 38: 781–790
Zhang Y, Dong D, Yang B. A trial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation. Sci China Life Sci, 2011, 54: 1097–1102
Feng W, Feng Y. microRNAs in neural cell development and brain diseases. Sci China Life Sci, 2011, 54: 1103–1112
Feng Y, Yu X. Cardinal roles of miRNA in cardiac development and disease. Sci China Life Sci, 2011, 54: 1113–1120
Li S, Yu B, Wang Y, Yao D, Zhang Z, Gu X. Identification and functional annotation of novel microRNAs in the proximal sciatic nerve after sciatic nerve transection. Sci China Life Sci, 2011, 54: 806–812
Yang C, Wei W. The miRNA expression profile of the uveal melanoma. Sci China Life Sci, 2011, 54: 351–358
Zhang LM, Deng T, Li XY, Liu HY, Zhou HD, Ma J, Wu MH, Zhou M, Shen SR, Niu ZX, Zhang WL, Shi L, Xiang B, Lu JH, Wang L, Li D, Tang HL, Li GY. microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis, 2010, 31: 559–566
Gong ZJ, Huang HB, Xu K, Liang F, Li XL, Xiong W, Zeng ZY, Li GY. Advances in microRNAs and TP53 gene regulatory network. Prog Biochem Biophys, 2012, 39: 1133–1144
Zhu YM, Xu Q, Dong LR, Liu ZM. Identification of proteins associated with let-7a in gastric carcinoma cell line SGC-7901 by proteomics. Prog Biochem Biophys, 2011, 38: 441–448
Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog, 2006, 2: e23
Lung RW, Tong JH, Sung YM, Leung PS, Ng DC, Chau SL, Chan AW, Ng EK, Lo KW, To KF. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia, 2009, 11: 1174–1184
Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, To KF, Kwong DL, Tsao SW, Jin DY. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med, 2008, 205: 2551–2560
Marquitz AR, Mathur A, Nam CS, Raab-Traub N. The Epstein-Barr virus BART microRNAs target the pro-apoptotic protein Bim. Virology, 2011, 412: 392–400
Iizasa H, Wulff BE, Alla NR, Maragkakis M, Megraw M, Hatzigeorgiou A, Iwakiri D, Takada K, Wiedmer A, Showe L, Lieberman P, Nishikura K. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J Biol Chem, 2010, 285: 33358–33370
Sturn A, Quackenbush J, Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics, 2002, 18: 207–208
Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120: 15–20
Elefant N, Berger A, Shein H, Hofree M, Margalit H, Altuvia Y. RepTar: a database of predicted cellular targets of host and viral miRNAs. Nucleic Acids Res, 2010, 39: D188–194
Huang H, Liang F, Xiong W, Li X, Zeng ZY, Li GY. Bioinformatics accelerates drug repositioning. Prog Biochem Biophys, 2012, 39: 35–44
Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol, 2003, 4: P3
Zeng ZY, Zhou YH, Xiong W, Luo XM, Zhang WL, Li XY, Fan SQ, Cao L, Tang K, Wu MH, Li GY. Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol, 2007, 133: 71–81
Zeng ZY, Zhou YH, Zhang WL, Xiong W, Fan SQ, Li XL, Luo XM, Wu MH, Yang YX, Huang C, Cao L, Tang K, Qian J, Shen SR, Li GY. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol, 2007, 38: 120–133
Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA, 2001, 98: 5116–5121
Zeng ZY, Zhou YH, Zhang WL, Li XY, Xiong W, Liu HY, Fan SQ, Qian J, Wang L, Li Z, Shen SR, Li GY. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med, 2006, 8: 156–160
Zeng ZY, Huang HB, Zhang WL, Xiang B, Zhou M, Zhou YH, Ma J, Yi M, Li XY, Xiong W, Li GY. Nasopharyngeal carcinoma: Advances in genomics and molecular genetics. Sci China Life Sci, 2011, 54: 966–975
Huang H, Deng M, Zheng Y, Ma J, Zhang WL, Zhou YH, Liao QJ, Xiong W, Li XY, Zeng ZY, Li GY. Innate immune protein lactotransferrin prevents initiation and arrests progression of nasopharyngeal carcinoma. Prog Biochem Biophys, 2013, 40: 319–324
Zhang WL, Huang C, Gong ZJ, Zhao YH, Tang K, Li XY, Fan SQ, Shi L, Zhang P, Zhou YH, Huang DH, Liang F, Zhang XL, Wu MH, Cao L, Wang J, Li Y, Xiong W, Zeng ZY, Li GY. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Histol, 2013, 44: 545–554
Zhang WL, Zeng ZY, Fan S, Wang JR, Yang JB, Zhou YH, Li XY, Huang DH, Liang F, Wu MH, Tang K, Cao L, Xiong W, Li GY. Evaluation of the prognostic value of TGF-beta superfamily type I receptor and TGF-beta type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays. J Mol Histol, 2012, 43: 297–306
Yang YX, Liao QJ, Wei F, Li XL, Zhang WL, Fan S, Shi L, Gong ZJ, Ma J, Zhou M, Xiang JJ, Peng SP, Xiang B, Deng H, Yang YB, Li Y, Xiong W, Zeng ZY, Li GY. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS ONE, 2013, 8: e62869
Liao QJ, Zeng ZY, Guo XF, Li XL, Wei F, Zhang WL, Li XY, Chen P, Liang F, Xiang B, Ma J, Wu MH, Tang HL, Deng M, Zeng X, Tang K, Xiong W, Li GY. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene, 2013, doi: 10.1038/onc.2013.161
Imig J, Motsch N, Zhu JY, Barth S, Okoniewski M, Reineke T, Tinguely M, Faggioni A, Trivedi P, Meister G, Renner C, Grasser FA. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res, 2011, 39: 1880–1893
Ambinder RF. Gammaherpesviruses and “Hit-and-Run” oncogenesis. Am J Pathol, 2000, 156: 1–3
Niller HH, Wolf H, Minarovits J. Viral hit and run-oncogenesis: Genetic and epigenetic scenarios. Cancer Lett, 2011, 305: 200–217
Sun XJ, Zhou QB, Zhao M, Li S, Guo HY, Wu Q, Huang CZ. Overexpression of serum and glucocorticoid-regulated kinase 2 alpha Inhibits proliferation of liver cancer cell line BEL7402 via Wnt/beta-catenin signal pathway. Prog Biochem Biophys, 2010, 37: 496–502
Wong AM, Kong KL, Tsang JW, Kwong DL, Guan XY. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer, 2011, 118: 698–710
Liang F, Xu K, Gong ZJ, Li Q, Ma J, Xiong W, Zeng ZY, Li GY. ChIP-seq: a new technique for genome-wide profiling of proteins-DNA interaction. Prog Biochem Biophys, 2013, 40: 216–227
Salim A, Ratner L. Modulation of beta-catenin and E-cadherin interaction by Vpu increases human immunodeficiency virus type 1 particle release. J Virol, 2008, 82: 3932–3938
Bour S, Perrin C, Akari H, Strebel K. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. J Biol Chem, 2001, 276: 15920–15928
Coadou G, Gharbi-Benarous J, Megy S, Bertho G, Evrard-Todeschi N, Segeral E, Benarous R, Girault JP. NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP. Biochemistry, 2003, 42: 14741–14751
Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Fruh K, Moses AV. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta} TrCP-dependent mechanism. J Virol, 2009, 83: 7931–7947
Margottin F, Bour SP, Durand H, Selig L, Benichou S, Richard V, Thomas D, Strebel K, Benarous R. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell, 1998, 1: 565–574
Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, Ruiz A, Stephens EB, Margottin-Goguet F, Benarous R, Guatelli JC. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endolysosomal trafficking. PLoS Pathog, 2009, 5: e1000450
Wan M, Huang J, Jhala NC, Tytler EM, Yang L, Vickers SM, Tang Y, Lu C, Wang N, Cao X. SCF(beta-TrCP1) controls Smad4 protein stability in pancreatic cancer cells. Am J Pathol, 2005, 166: 1379–1392
He N, Li C, Zhang X, Sheng T, Chi S, Chen K, Wang Q, Vertrees R, Logrono R, Xie J. Regulation of lung cancer cell growth and invasiveness by beta-TRCP. Mol Carcinog, 2005, 42: 18–28
Tang W, Pavlish OA, Spiegelman VS, Parkhitko AA, Fuchs SY. Interaction of Epstein-Barr virus latent membrane protein 1 with SCFHOS/beta-TrCP E3 ubiquitin ligase regulates extent of NF-kappaB activation. J Biol Chem, 2003, 278: 48942–48949
Ishov AM, Maul GG. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol, 1996, 134: 815–826
Tsai K, Thikmyanova N, Wojcechowskyj JA, Delecluse HJ, Lieberman PM. EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription. PLoS Pathog, 2012, 7: e1002376
Jurak I, Silverstein LB, Sharma M, Coen DM. Herpes simplex virus is equipped with RNA- and protein-based mechanisms to repress the expression of ATRX, an effector of intrinsic immunity. J Virol, 2012, 86: 10093–10102
Chen RS. Noncoding RNAs: an important area to be studied in life science. Prog Biochem Biophys, 2013, 40: 591–592
Li B, Guo YH, Xu H, Zhou H, Qu LH. The reciprocal interactions of microRNAs and cell signaling pathways. Prog Biochem Biophys, 2013, 40: 593–602.
Liang H, Gong F, Zhang S, Zhang CY, Zen K, Chen X. The origin, function and diagnostic potential of extracellular microRNA in human body fluids. Prog Biochem Biophys, 2013, 40: 603–616
Li J, Qin XL, Shao NS. Time and space specificity and dynamic change of microRNA and its targets. Prog Biochem Biophys, 2013, 40: 617–626
Yuan JP, Zhang H W, Lu Z. Progress on bioinformatic research of lncRNA. Prog Biochem Biophys, 2013, 40: 634–640
Tang K, Wei F, Bo H, Huang HB, Zhang WL, Gong ZJ, Li XY, Song YL, Liao QJ, Peng SP, Xiang JJ, Zhou Ming, Ma J, Li XL, Xiong W, Li Y, Zeng ZY, Li GY. Cloning and functional characterization of a novel long non-coding RNA gene associated with hepatocellular carcinoma. Prog Biochem Biophys, 2013, 40
Author information
Authors and Affiliations
Corresponding authors
Additional information
This article is published with open access at link.springer.com
Electronic supplementary material
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Zeng, Z., Huang, H., Huang, L. et al. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Sci. China Life Sci. 57, 315–326 (2014). https://doi.org/10.1007/s11427-013-4577-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-013-4577-y